Abstract
Liver transplantion is the treatment for end stage chronic liver diasese, acute liver failure with massive liver necrosis, malignant liver tumors, and chronic metabolic or genetic diseases. The interpretation of liver biopsies to evaluate the donor liver as well as the changes that occur after transplant requires specialized knowledge related to liver transplantation such as the following: graft preservation/reperfusion injury, vascular and biliary tract injuries, cell mediated and antibody mediated rejection, complications of immunosuppression, and recurrence of original liver disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Demetris AJ, Crawford JM, Isse K, et al. Pathology of liver and hematopoietic stem cell transplantation. In: Odze RD, Goldblum JR, editors. Surgical pathology of the GI tract, liver, biliary tract, and pancreas. 3rd ed. Philadelphia, PA: Elsevier Saunders; 2015. p. 1408–61.
Hübscher SG, Clouston AD. Transplantation pathology. In: Burt AD, Portman BC, Ferrell LD, editors. MacSween’s pathology of the liver. 6th ed. Edinburgh: Elsevier Churchill Livingstone; 2012. p. 853–933.
Swerdlow SH, Webber SA, Chadburn A, Ferry JA. Post-transplant lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris N, editors. WHO classification of lymphoproliferative disorders. Lyons: IARC Press; 2008. p. 343–6.
Torbenson M. Biopsy interpretation of the liver. Philadelphia, PA: Wolters Kluwer Health; 2015.
Xiao S-Y, Oshima K. Liver pathology. New York, NY: Demos Medical; 2015.
Bardou-Jacquet E, Philip J, Lorho R, et al. Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations in HFE hemochromatosis. Hepatology. 2014;59:839–47.
Kerkar N, Morotti RA, Madan RP, et al. The changing face of post-transplant lymphoproliferative disease in the era of molecular EBV monitoring. Pediatr Transplant. 2010;14:504–11.
Kim H, Lee K, Lee KW, et al. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation. Clin Transplant. 2014;28:521–9.
Lo RC, Chan SC, Chan KL, et al. Post-transplant lymphoproliferative disorders in liver transplant recipients: a clinicopathological study. J Clin Pathol. 2013;66:392–8.
Patil DT, Yerian LM. Evolution of nonalcoholic fatty liver disease recurrence after liver transplantation. Liver Transpl. 2012;18:1147–53.
Piselli P, Busnach G, Fratino L, et al. Immunosuppression and Cancer Study Group. De novo malignancies after organ transplantation: focus on viral infections. Curr Mol Med. 2013;13:1217–27.
Said A. Non-alcoholic fatty liver disease and liver transplantation: outcomes and advances. World J Gastroenterol. 2013;19:9146–55.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
O’Neil, M., Damjanov, I., Taylor, R.M. (2015). Liver Transplantation Pathology. In: Liver Pathology for Clinicians. Pathology for Clinicians. Springer, Cham. https://doi.org/10.1007/978-3-319-20080-4_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-20080-4_7
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-20079-8
Online ISBN: 978-3-319-20080-4
eBook Packages: MedicineMedicine (R0)